196 related articles for article (PubMed ID: 35709886)
1. Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
Schwab K; Chasapopoulou Z; Frahm S; Magbagbeolu M; Cranston A; Harrington CR; Wischik CM; Theuring F; Riedel G
Cell Signal; 2022 Sep; 97():110386. PubMed ID: 35709886
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
3. Solubility of α-synuclein species in the L62 mouse model of synucleinopathy.
Schwab K; Magbagbeolu M; Theuring F; Harrington CR; Wischik CM; Riedel G
Sci Rep; 2024 Mar; 14(1):6239. PubMed ID: 38486089
[TBL] [Abstract][Full Text] [Related]
4. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
[TBL] [Abstract][Full Text] [Related]
5. LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy.
Schwab K; Frahm S; Magbagbeolu M; Horsley D; Goatman EA; Melis V; Theuring F; Ishaq A; Storey JMD; Harrington CR; Wischik CM; Riedel G
Eur J Pharmacol; 2024 May; 970():176505. PubMed ID: 38503400
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca(2+) influx upon NMDA stimulation.
Chen Y; Yang W; Li X; Li X; Yang H; Xu Z; Yu S
Neuroscience; 2015 Aug; 300():297-306. PubMed ID: 26003734
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
[TBL] [Abstract][Full Text] [Related]
8. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
9. GV-971 attenuates α-Synuclein aggregation and related pathology.
Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
[TBL] [Abstract][Full Text] [Related]
10. Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors.
Schwab K; Lauer D; Magbagbeolu M; Theuring F; Gasiorowska A; Zadrozny M; Harrington CR; Wischik CM; Niewiadomska G; Riedel G
Brain Res Bull; 2024 Jun; 212():110955. PubMed ID: 38677558
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.
Koob AO; Ubhi K; Paulsson JF; Kelly J; Rockenstein E; Mante M; Adame A; Masliah E
Exp Neurol; 2010 Feb; 221(2):267-74. PubMed ID: 19944097
[TBL] [Abstract][Full Text] [Related]
12. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Accumulation of α-Synuclein Aggregates Promotes S-Nitrosylation of MAP1A Leading to Decreased NMDAR-Evoked Calcium Influx and Loss of Mature Synaptic Spines.
Hallam RD; Buchner-Duby B; Stykel MG; Coackley CL; Ryan SD
J Neurosci; 2022 Dec; 42(50):9473-9487. PubMed ID: 36414406
[TBL] [Abstract][Full Text] [Related]
14.
Dutta AK; Armstrong C; Luo D; Das B; Spencer B; Rissman RA
ACS Chem Neurosci; 2023 Mar; 14(5):885-896. PubMed ID: 36749600
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
Durante V; de Iure A; Loffredo V; Vaikath N; De Risi M; Paciotti S; Quiroga-Varela A; Chiasserini D; Mellone M; Mazzocchetti P; Calabrese V; Campanelli F; Mechelli A; Di Filippo M; Ghiglieri V; Picconi B; El-Agnaf OM; De Leonibus E; Gardoni F; Tozzi A; Calabresi P
Brain; 2019 May; 142(5):1365-1385. PubMed ID: 30927362
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.
Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS
Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916
[TBL] [Abstract][Full Text] [Related]
20. A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.
Schwab K; Frahm S; Horsley D; Rickard JE; Melis V; Goatman EA; Magbagbeolu M; Douglas M; Leith MG; Baddeley TC; Storey JMD; Riedel G; Wischik CM; Harrington CR; Theuring F
Front Mol Neurosci; 2017; 10():447. PubMed ID: 29375308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
